• We are a biotech company in
    infectious diseases with a
    first marketed product.

  • Dedicated to innovation in
    vaccine research & development.

  • Valneva covers the full
    value chain from bench
    to market.

Welcome to Valneva

Joining forces to create a European biotech leader in vaccines


— February 26, 2015

Valneva Reports Significantly Improved Preliminary Full Year 2014 Results
Press release

— Stock information



—News, Jan. 29, 2015

Valneva Grants License to Immune Targeting Systems for Develop-ment of Hepatitis B Vaccines in Combination with IC31®  
 All News

— Financial calendar

 All dates     


– Upcoming conferences and fairs

March 9 - 11, 2015
BioEurope Spring
Paris, France

May 24 - 28, 2015
CISTM14 – 14th conference of the International Society of Travel Medicine
Québec City, Canada

June 15 - 18, 2015
Bio International Convention
Philadelphia, United States

Meet our Business Development team

European biotech company with worldwide presence.

Please update your browser...